| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00058188 Details | 2020-12-08 Interventional | 3 | 53 | Calcium Cholecalciferol Vitamin D Zoledronic Acid Osteoporosis Prostatic Neopl… Prostate Cancer | Closed by the research committee - | |||
| NCT02566707 Details | 2020-12-07 Interventional | 2 | 9 | Atazanavir Sulf… Dolutegravir Lamivudine HIV-1 Infection | due to introduction of another integrase inhibitor, recruitement was not feasible anymore. - | |||
| NCT01607346 2012-002260-26 Details | 2020-12-04 Interventional | 4 | 10 | Ezogabine Seizures Epilepsy | - The study was terminated after 10 of 100 subjects had been enrolled. Statistical analyses were not performed as the sample size enrolled was too small to allow for these analyses to be meaningful. The data are presented as summary statistics only. | |||
| NCT00673920 Details | 2020-12-04 Interventional | 3 | 314 | Methotrexate Ocrelizumab Arthritis Arthritis, Rheu… Rheumatoid Arth… | Based on analysis of results and consideration of available treatments, the overall benefit to
risk profile of ocrelizumab was not favorable in RA. - | |||
| NCT03655444 Details | 2020-12-03 Interventional | 1/2 | 6 | Nivolumab Carcinoma Carcinoma, Squa… Squamous Cell C… Head and Neck S… | Provider of drug decided to discontinue study. - | |||
| NCT03426995 2017-003997-15 Details | 2020-12-02 Interventional | 1 | 48 | Cantharidin Arthritis, Rheu… | The trial was terminated for strategic reasons following the emergence of new data. - | |||
| NCT03597022 2017-003324-67 Details | 2020-11-30 Interventional | 2 | 24 | Immunoglobulin … Immunoglobulins Lipoprotein-ass… Hemophilia A Hemophilia A an… | Due to thrombosis Acceptable safety and tolerability of befovacimab was not demonstrated in the study, prompting early termination of the study. The "post-hoc" SAP was used for analyses. The other SAP was pre-specified but became not applicable after the termination. | |||
| NCT01908751 Details | 2020-11-30 Interventional | 3 | 91 | Cholecalciferol Ergocalciferols Vitamin D Vitamins Femoral Neck Fr… Fractures, Bone Hip Fractures | Continuing beyond the pilot phase of the trial was deemed unfeasible - | |||
| NCT01494584 Details | 2020-11-30 Interventional | 2 | 5 | Ezogabine Epilepsy | Terminated after placing the study on hold at the request of the FDA - | |||
| NCT00588835 2007-003347-73 Details | 2020-11-30 Interventional | 4 | - | Aprepitant Dexamethasone Ondansetron Tumor | - - | |||
| NCT03206788 Details | 2020-11-27 Interventional | 2 | 7 | Losartan Cystic Fibrosis Fibrosis | due to slow enrollment and approval of the Trikafta for CF patients - | |||
| NCT00406419 Details | 2020-11-27 Interventional | 3 | 1015 | Methotrexate Ocrelizumab Arthritis Arthritis, Rheu… Rheumatoid Arth… | Based on analysis of results and consideration of available treatments, the overall benefit to
risk profile of ocrelizumab was not favorable in RA. - | |||
| NCT02538614 Details | 2020-11-25 Interventional | 1 | 2 | BI 836826 Idelalisib Leukemia Leukemia, Lymph… Leukemia, Lymph… Chronic Lymphoc… | - - | |||
| NCT02435095 Details | 2020-11-25 Interventional | 4 | 174 | Antipsychotic A… Schizophrenia | slow patient recruitment, low patient-commpliance, high dropout rates, - | |||
| NCT04290442 Details | 2020-11-24 Interventional | 4 | 0 | Ropivacaine Acute Pain Anesthesia, Con… Arthroplasty, R… | initially cessation due to covid, then fellow doing the study graduated with no time to
complete the study; will take up again if a current fellow takes on the project - | |||
| NCT02882711 Details | 2020-11-24 Interventional | 2 | 10 | Ketamine Bipolar Disorde… Depression Depressive Diso… Depressive Diso… Depressive Diso… Major Depressiv… Treatment Resis… | Increasing off-label practice of IV ketamine administration for treatment-resistant depression. Not reaching the target number of participants needed to achieve target power | |||
| NCT00269828 NCT00317824 Details | 2020-11-24 Interventional | 3 | - | Albumin-Bound P… Paclitaxel Paclitaxel poli… Lung Neoplasms NSCLC | - - | |||
| NCT00079911 Details | 2020-11-24 Interventional | 4 | 7 | Valacyclovir Herpes Genitali… Herpes Simplex | Terminated - | |||
| NCT03488147 Details | 2020-11-23 Interventional | 2 | 0 | Esomeprazole Deglutition Dis… Joint Diseases Osteoarthritis Degenerative Jo… Dysphagia GERD | Change in Investigational Drug Service policies resulting in the need to change the operational
design of the overall protocol. - | |||
| NCT04365231 Details | 2020-11-20 Interventional | 3 | 0 | Azithromycin Hydroxychloroqu… COVID-19 COVID19 | no authorization obtained - |